News
The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...
The Canadian pharmaceutical industry is still waiting to learn about tariffs as high as 200 per cent on exports to the U.S.
Trump is using Section 232 and his Most Favoured Nation policy as twin levers in his push to lower drug prices.
After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma ...
At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal with the European Union. | As part of a trade agreement reached Sunday ...
Indian pharmaceutical industry leaders strongly criticize U.S. President Trump's tariff announcement, arguing it will harm ...
Uncertainty looms for Indian drugmakers exporting to the US amid potential tariffs and trade discussions, impacting ...
Varda Space Industries, based in El Segundo, makes drugs in space. But Will Bruey, Varda co-founder and chief executive, says ...
DoP extends timeline for industry to file self-declaration under UCPMP for FY 2024-25: Gireesh Babu, New Delhi Monday, August 4, 2025, 08:00 Hrs [IST] The Department of Pharmaceut ...
Iraq's drug localization efforts save $1B annually, with 34 factories at full capacity & 178 new applications, says PM's ...
Evolving trade policies and tariffs strain bio/pharmaceutical manufacturers, affecting profits and operational strategies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback